ClinConnect ClinConnect Logo
Search / Trial NCT06665321

Internet-based Affect Focused Psychodynamic Therapy for Neuroticism: a Randomized Controlled Trial

Launched by LINKOEPING UNIVERSITY · Oct 29, 2024

Trial Information

Current as of November 12, 2025

Not yet recruiting

Keywords

Trait Neuroticism Internet Delivered Psychodynamic Therapy Internet Intervention

ClinConnect Summary

This clinical trial is studying a type of online therapy called Internet-based Affect Focused Psychodynamic Therapy (IPDT) to see if it can help reduce levels of trait neuroticism, which is a tendency to experience negative emotions like anxiety and depression. The trial aims to find out if people who take part in this therapy will feel better compared to those who are simply on a waiting list for treatment. The program consists of 8 online modules that participants will complete over 9 weeks, with support from a therapist.

To be eligible for the trial, you need to be at least 18 years old, speak, read, and write in Swedish, and have mild to moderate symptoms of anxiety or depression. You also need access to the internet and a device like a smartphone or computer. However, if you have severe mental health issues, are struggling with addiction, or are currently receiving other psychological treatment, this trial may not be suitable for you. The study is not yet recruiting participants, but it aims to help people manage their emotions better through this new online therapy approach.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Score 5 points or more on either the PHQ-9 or GAD-7
  • 18 years or older
  • Ability to speak, read and write in Swedish
  • Have access to the internet and a smartphone, computer or other device
  • Exclusion Criteria:
  • Severe psychiatric or somatic illness that makes participation difficult or impossible
  • Ongoing addiction
  • Acute suicidality
  • Other ongoing psychological treatment
  • Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks

About Linkoeping University

Linköping University is a leading academic institution in Sweden, renowned for its innovative research and commitment to advancing medical science. With a strong emphasis on interdisciplinary collaboration, the university facilitates cutting-edge clinical trials aimed at improving patient outcomes and enhancing healthcare delivery. Linköping University’s research initiatives are supported by state-of-the-art facilities and a robust network of partnerships with healthcare providers, industry stakeholders, and regulatory bodies, ensuring rigorous methodologies and ethical standards in all clinical investigations. Through its dedication to research excellence, Linköping University plays a pivotal role in translating scientific discoveries into practical applications that benefit society.

Locations

Linköping, östergörland, Sweden

Linköping, Sweden

Patients applied

0 patients applied

Trial Officials

Gerhard Andersson, PhD

Principal Investigator

Linkoeping University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported